Howard Levy

Insider

First SEC filing: Jan. 16, 2018 · Latest: Jan. 16, 2018

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

GYRE buying Aug. 9, 2021

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Aug. 9, 2021	GYRE	P	639	$3.62	$2,313	639 Direct	—	Acquired	-86.7% (price as of 2026-08-19)
Feb. 9, 2021	GYRE	P	1,670	$4.81	$8,033	23,390 Indirect	+7.69%	Acquired	-90.0% (price as of 2026-08-19)
Feb. 8, 2021	GYRE	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-19)
Feb. 8, 2021	GYRE	A	25,000	—	—	25,000 Direct	—	Acquired	(price as of 2026-08-19)
Aug. 10, 2020	GYRE	P	1,768	$4.81	$8,504	4,268 Direct	+70.72%	Acquired	-90.0% (price as of 2026-08-19)
March 16, 2020	GYRE	P	2,500	$4.05	$10,125	2,500 Direct	—	Acquired	-88.1% (price as of 2026-08-19)
Feb. 10, 2020	GYRE	A	1,358	$6.23	$8,460	1,358 Direct	—	Acquired	-92.3% (price as of 2026-08-19)
Jan. 23, 2020	GYRE	A	45,000	—	—	45,000 Direct	—	Acquired	(price as of 2026-08-19)
May 21, 2019	GYRE	G	16,094	—	—	16,094 Indirect	-50.00%	Disposed	(price as of 2026-08-19)
May 21, 2019	GYRE	M	4,400	$4.63	$20,372	16,094 Direct	+37.63%	Acquired	-89.6% (price as of 2026-08-19)
May 20, 2019	GYRE	M	4,400	—	—	81,218 Direct	-5.14%	Disposed	(price as of 2026-08-19)
Feb. 11, 2019	GYRE	A	2,485	$7.04	$17,494	11,867 Direct	+26.49%	Acquired	-93.2% (price as of 2026-08-19)
Jan. 31, 2019	GYRE	M	1,500	—	—	93,500 Direct	-1.58%	Disposed	(price as of 2026-08-19)
Jan. 31, 2019	GYRE	M	1,500	$4.63	$6,945	9,382 Direct	+19.03%	Acquired	-89.6% (price as of 2026-08-19)
Jan. 24, 2019	GYRE	A	35,000	—	—	35,000 Direct	—	Acquired	(price as of 2026-08-19)
Nov. 26, 2018	GYRE	M	149	—	—	87,118 Direct	-0.17%	Disposed	(price as of 2026-08-19)
Nov. 26, 2018	GYRE	M	149	$4.63	$690	7,709 Direct	+1.97%	Acquired	-89.6% (price as of 2026-08-19)
Nov. 16, 2018	GYRE	M	173	—	—	87,267 Direct	-0.20%	Disposed	(price as of 2026-08-19)
Nov. 16, 2018	GYRE	S 10b5-1	173	$11.00	$1,903	7,560 Direct	-2.24%	Disposed	-95.6% (price as of 2026-08-19)
Nov. 16, 2018	GYRE	M	173	$4.63	$801	7,733 Direct	+2.29%	Acquired	-89.6% (price as of 2026-08-19)
July 30, 2018	GYRE	A	35,000	—	—	35,000 Direct	—	Acquired	(price as of 2026-08-19)
May 3, 2018	GYRE	M	7,560	—	—	87,440 Direct	-7.96%	Disposed	(price as of 2026-08-19)
May 3, 2018	GYRE	M	7,560	$4.63	$35,003	7,560 Direct	—	Acquired	-89.6% (price as of 2026-08-19)
Jan. 12, 2018	GYRE	A	33,000	—	—	33,000 Direct	—	Acquired	(price as of 2026-08-19)
July 11, 2017	GYRE	A	95,000	—	—	95,000 Direct	—	Acquired	(price as of 2026-08-19)
April 18, 2016	GYRE	A	100,000	—	—	100,000 Direct	—	Acquired	(price as of 2026-08-19)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 8, 2021	GYRE	Stock Option (Right to Buy)	Common Stock (25,000)	$5.89	Feb. 8, 2031	25,000	Acquired
Feb. 8, 2021	GYRE	Stock Option (Right to Buy)	Common Stock (25,000)	$5.89	Feb. 8, 2031	25,000	Acquired
Jan. 23, 2020	GYRE	Stock Option (Right to Buy)	Common Stock (45,000)	$6.85	Jan. 23, 2030	45,000	Acquired
May 20, 2019	GYRE	Stock Option (Right to Buy)	Common Stock (4,400)	$4.63	July 11, 2027	4,400	Disposed
Jan. 31, 2019	GYRE	Stock Option (Right to Buy)	Common Stock (1,500)	$4.63	July 11, 2027	1,500	Disposed
Jan. 24, 2019	GYRE	Stock Option (Right to Buy)	Common Stock (35,000)	$7.97	Jan. 24, 2029	35,000	Acquired
Nov. 26, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (149)	$4.63	July 11, 2027	149	Disposed
Nov. 16, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (173)	$4.63	July 11, 2027	173	Disposed
July 30, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (35,000)	$9.68	July 30, 2028	35,000	Acquired
May 3, 2018	GYRE	Stock Option (Right to Buy)	Common Stock (7,560)	$4.63	July 11, 2027	7,560	Disposed
Jan. 12, 2018	GYRE	Stock Option(Right to Buy)	Common Stock (33,000)	$15.13	Jan. 12, 2028	33,000	Acquired
July 11, 2017	GYRE	Stock Option (Right to Buy)	Common Stock (95,000)	$4.63	July 11, 2017	95,000	Acquired
April 18, 2016	GYRE	Stock Option (Right to Buy) [F1]	Common Stock (100,000)	$1.52	April 18, 2026	100,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

GYRE

M.B.B.Ch., Ph.D., M.M.MChief Medical Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2020	$450,348	—	—	—	$112,342	—	$14,349	$826,709
2019	$419,500	—	—	—	$110,000	—	$4,239	$733,018
2018	$397,838	$139,230	—	—	—	—	$3,317	$1,198,847

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.